Literature DB >> 12814982

Natural history of venous thromboembolism.

Clive Kearon1.   

Abstract

Most deep vein thromboses (DVTs) start in the calf, and most probably resolve spontaneously. Thrombi that remain confined to the calf rarely cause leg symptoms or symptomatic pulmonary embolism (PE). The probability that calf DVT will extend to involve the proximal veins and subsequently cause PE increases with the severity of the initiating prothrombotic stimulus. Although acute venous thromboembolism (VTE) usually presents with either leg or pulmonary symptoms, most patients have thrombosis at both sites at the time of diagnosis. Proximal DVTs resolve slowly during treatment with anticoagulants, and thrombi remain detectable in half of the patients after a year. Resolution of DVT is less likely in patients with a large initial thrombus or cancer. About 10% of patients with symptomatic DVTs develop severe post-thrombotic syndrome within 5 years, and recurrent ipsilateral DVT increases this risk. About 10% of PEs are rapidly fatal, and an additional 5% cause death later, despite diagnosis and treatment. About 50% of diagnosed PEs are associated with right ventricular dysfunction, which is associated with a approximately 5-fold greater in-hospital mortality. There is approximately 50% resolution of PE after 1 month of treatment, and perfusion eventually returns to normal in two thirds of patients. About 5% of treated patients with PE develop pulmonary hypertension as a result of poor resolution. After a course of treatment, the risk of recurrent thrombosis is higher (ie, approximately 10% per patient-year) in patients without reversible risk factors, in those with cancer, and in those with prothrombotic biochemical abnormalities such as antiphospholipid antibodies and homozygous factor V Leiden.

Entities:  

Mesh:

Year:  2003        PMID: 12814982     DOI: 10.1161/01.CIR.0000078464.82671.78

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  197 in total

1.  Elevated plasma gas6 levels are associated with venous thromboembolic disease.

Authors:  Mark D Blostein; Isabelle Rajotte; Deepa P Rao; Christina A Holcroft; Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

2.  Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Authors:  F Borgström; O Ström; M Kleman; E McCloskey; H Johansson; A Odén; J A Kanis
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

Review 3.  Managing pulmonary embolism using prognostic models: future concepts for primary care.

Authors:  Geert-Jan Geersing; Ruud Oudega; Arno W Hoes; Karel G M Moons
Journal:  CMAJ       Date:  2011-12-05       Impact factor: 8.262

Review 4.  The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests.

Authors:  Behrouz Kassaï; Nirav R Shah; Alain Leizorovicza; Michel Cucherat; Francois Gueyffier; Jean-Pierre Boissel
Journal:  J Clin Epidemiol       Date:  2005-10       Impact factor: 6.437

5.  Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus.

Authors:  Sangjun Yoo; Sang Hoon Song; Heounjeong Go; Dalsan You; Cheryn Song; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn; In Gab Jeong
Journal:  Int Urol Nephrol       Date:  2017-04-11       Impact factor: 2.370

6.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 7.  Deep vein thrombosis: pathogenesis, diagnosis, and medical management.

Authors:  Jonathan Stone; Patrick Hangge; Hassan Albadawi; Alex Wallace; Fadi Shamoun; M Grace Knuttien; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 8.  Rationale for catheter directed therapy in pulmonary embolism.

Authors:  Sailen G Naidu; Martha-Gracia Knuttinen; J Scott Kriegshauser; William G Eversman; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 9.  Can thrombus age guide thrombolytic therapy?

Authors:  Christopher Czaplicki; Hassan Albadawi; Sasan Partovi; Ripal T Gandhi; Keith Quencer; Amy R Deipolyi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

10.  Study of clinical profile and management of patients with pulmonary embolism - single center study.

Authors:  S Calwin Davidsingh; Narayanan Srinivasan; P Balaji; U Kalaichelvan; Ajit Sankaradas Mullasari
Journal:  Indian Heart J       Date:  2014-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.